Tumor‐microenvironment‐responsive nanomedicine for enhanced cancer immunotherapy
S Peng, F **_Antitumor_Immunity_with_Chemo-Photothermal_Integrated_Nanoplatform_to_Augment_Checkpoint_Blockade-Based_Cancer_Therapy/links/611f5bfe0c2bfa282a58c118/Resha**-Antitumor-Immunity-with-Chemo-Photothermal-Integrated-Nanoplatform-to-Augment-Checkpoint-Blockade-Based-Cancer-Therapy.pdf" data-clk="hl=nl&sa=T&oi=gga&ct=gga&cd=7&d=8089098554993234570&ei=miexZ5vnGPqu6rQPmsSPUA" data-clk-atid="ilJ_I0dAQnAJ" target="_blank">[PDF] researchgate.net
Resha** antitumor immunity with chemo‐photothermal integrated nanoplatform to augment checkpoint blockade‐based cancer therapy
T Gao, Z Zhang, S Liang, S Fu, W Mu… - Advanced Functional …, 2021 - Wiley Online Library
Immune checkpoint therapy promotes cytotoxic T lymphocytes (CTLs) activity to eliminate
tumors. Nevertheless, their effectiveness in solid tumors is limited by inadequate infiltration …
tumors. Nevertheless, their effectiveness in solid tumors is limited by inadequate infiltration …
A tauopathy-homing and autophagy-activating nanoassembly for specific clearance of pathogenic tau in Alzheimer's disease
The hyperphosphorylated and aggregated tau accumulation represents a significant
pathological hallmark of tauopathies including Alzheimer's disease (AD), which is highly …
pathological hallmark of tauopathies including Alzheimer's disease (AD), which is highly …
[HTML][HTML] Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives
Y Wang, S Chen, C Wang, F Guo - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cancer is the second-most lethal global disease, as per health reports, and is responsible
for around 70% of deaths in low-and middle-income countries. Endometrial cancer is one of …
for around 70% of deaths in low-and middle-income countries. Endometrial cancer is one of …